STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer’s disease

STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer’s disease
Quinney SK, Murugesh K, Oblak A, Onos KD, Sasner M, Greenwood AK, Woo KH, Sukoff Rizzo SJ, Territo PR

https://pubmed.ncbi.nlm.nih.gov/37157089/